Home › Research › Health systems and care delivery
Implications of Medicare Advantage for Patients With Alzheimer Disease and Related Dementias
David M Dosa, Amal N. Trivedi, Vincent Mor. JAMA Network Open, 2020-03-30
Topic: Risk, prevention and care in population studies
fewer functional limitations in the MA population, perhaps explaining why those patients had fewer health care visits.The study by Park et al 4 of patients with ADRD suggests that those enrolled in MA plans received fewer health services compared with patients enrolled in TM.These differences in care could reflect selection of a less-impaired slice of the population with ADRD, differential disenrollment of high-need patients with ADRD out of MA plans, restricted access to effective care, or moreefficient health care delivery.More research will need to be done to fully understand the implications of managed care for patients with ADRD and other complex medical conditions.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Dosa, D. M., Trivedi, A. N., & Mor, V. (2020). Implications of Medicare Advantage for Patients With Alzheimer Disease and Related Dementias. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2020.1853
Vancouver
Dosa DM, Trivedi AN, Mor V. Implications of Medicare Advantage for Patients With Alzheimer Disease and Related Dementias. JAMA Network Open. 2020. doi:10.1001/jamanetworkopen.2020.1853. PMID: 32227176.
BibTeX
@article{dosa2020-32227176,
author = {Dosa, David M and Trivedi, Amal N. and Mor, Vincent},
title = {{Implications of Medicare Advantage for Patients With Alzheimer Disease and Related Dementias}},
journal = {JAMA Network Open},
year = {2020},
doi = {10.1001/jamanetworkopen.2020.1853},
pmid = {32227176},
url = {https://doi.org/10.1001/jamanetworkopen.2020.1853}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- fewer functional limitations in the MA population, perhaps explaining why those patients had fewer health care visits.The study by Park et al 4 of patients with ADRD suggests that those enrolled in MA plans received fewer health services compared with patients enrolled in TM.These differences in care could reflect selection of a less-impaired slice of the population with ADRD, differential disenrollment of high-need patients with ADRD out of MA plans, restricted access to effective care, or moreefficient health care delivery.More research will need to be done to fully understand the implications of managed care for patients with ADRD and other complex medical conditions.
Why it matters
This commentary discusses differences in care between Medicare Advantage and traditional Medicare for patients with Alzheimer's disease and related dementias. It does not test any treatment, cure, or prevention, and it calls for more research to understand the implications of managed care for these patients.
Study details
- Evidence strengthLow
How this study scored 37/100
Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (JAMA Network Open) |
| Journal's citation record | 2 / 4 | JAMA Network Open: journal h-index 235 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.2 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 1 / 6 | Cited 0.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Vincent Mor: h-index 108 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Brown University: institution h-index 1,120 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 32227176) |
| Free to read | 2 / 2 | Free to read |
| Total | 37 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/jamanetworkopen.2020.1853
- PubMed: 32227176
- Original source →
- Free full text: JAMA Network Open →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Health systems and care delivery
Also in Health systems and care delivery
172 studies in the library are filed under Health systems and care delivery with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Health systems and care delivery hub.